In 2024, Hungary exhibits the highest Global Potential Years of Life Lost due to pancreas malignant neoplasms, followed by Bulgaria and the Czech Republic. The latest year-on-year changes show both declines and increases across countries, with Estonia experiencing the most significant reduction at -5.8%, while Iceland saw the most substantial increase at 11.66%. Over the past five years, differing CAGR values reflect various national healthcare challenges and advancements, emphasizing the importance of ongoing monitoring.
Future trends may include advancements in early detection and treatment techniques, potentially impacting these rates. Efforts towards understanding and addressing lifestyle risk factors globally will be crucial in reducing future potential years of life lost.
Top countries in Potential Years of Life Lost from Pancreas Malignant Neoplasms by Country
| # | 10 Countries | Years Per Hundred Thousand Persons Aged 0-69 | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Hungary | 125.2 | 2023 | -0.4% | -1.08% | View data |
| 2 | 2 Bulgaria | 107.4 | 2023 | +0.47% | +3.05% | View data |
| 3 | 3 Czech Republic | 107 | 2023 | -0.65% | 0% | View data |
| 4 | 4 Latvia | 106.5 | 2023 | -0.56% | -0.63% | View data |
| 5 | 5 Lithuania | 102.7 | 2023 | +3.84% | -0.14% | View data |
| 6 | 6 Romania | 99.9 | 2023 | -0.2% | -1.01% | View data |
| 7 | 7 Slovakia | 98.4 | 2023 | -0.71% | -1.12% | View data |
| 8 | 8 Croatia | 94.5 | 2023 | +2.83% | +0.6% | View data |
| 9 | 9 Austria | 93.4 | 2023 | -0.11% | +0.59% | View data |
| 10 | 10 Finland | 91.2 | 2023 | 0% | -1.23% | View data |
